Cart
sales@molnova.com
KRAS G12C inhibitor 16
CAS No. 2349392-79-4
KRAS G12C inhibitor 16( —— )
Catalog No. M32985 CAS No. 2349392-79-4
KRAS G12C inhibitor 16 is a potent inhibitor of KRAS G12C.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 695 | Get Quote |
|
| 5MG | 1007 | Get Quote |
|
| 10MG | 1349 | Get Quote |
|
| 25MG | 1950 | Get Quote |
|
| 50MG | 2558 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKRAS G12C inhibitor 16
-
NoteResearch use only, not for human use.
-
Brief DescriptionKRAS G12C inhibitor 16 is a potent inhibitor of KRAS G12C.
-
DescriptionKRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorKras
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2349392-79-4
-
Formula Weight453.89
-
Molecular FormulaC24H21ClFN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C2C(C=3N4[C@](CN(C(C=C)=O)CC4)(COC3C=N2)[H])=CC(Cl)=C1C5=C(F)C=CC=C5O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jason Grant Kettle, et al. Tetracyclic compounds as inhibitors of g12c mutant ras protein, for use as anti-cancer agents. WO2019110751A1.
molnova catalog
related products
-
Gatipotuzumab
Gatipotuzumab (PankoMab) is a novel humanized monoclonal antibody conjugated to the tumor-associated epitope of mucin 1 (TA-MUC1) with potential anti-tumor activity for the study of recurrent epithelial ovarian cancer.
-
Nortropinone hydroch...
Used as pharmaceutical intermediates.
-
DAPI Dihydrochloride
DAPI Dihydrochloride is a cell-permeable fluorescent probe by binding in the minor grove of A-T rich sequences of DNA, used to stain DNA and chromosomes, with a preference for adenine and thymine rich DNA.
